StockTipsArenaBeta

BUY Gland Pharma Limited — Rakesh Bansal

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byRakesh BansalHorizon: NA (inferred 1–3 months)23 Jun 2026via Zee Business (Live)

Entry₹2,251Stated
Target₹3,300
Total upside +46.60% (call closed)
Stop loss₹2,160-4.04% risk
At expiry₹2,916.623 Sept 2026, 3:30 pm
Expired+29.57%
Follow Rakesh Bansal for new calls(31% target hit, 26 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 4 active Short-term calls on GLANDSee 45 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 23 Sept 2026
22 supporting10 neutral5 opposing
Supports the BUY call (22)

Gland Pharma Ltd acquired Gland Pharma USA Inc., a wholly-owned step-down subsidiary, from Gland Pharma International Pte. Ltd.

BSE · Company Update·13 Sept · 1w ago

(opens in new tab)

Gland Pharma Limited's Board of Directors approved the acquisition of 100% equity share capital of Gland Pharma USA Inc., a step-down subsidiary, to streamline corporate structure. The acquisition is

BSE · Others·13 Sept · 1w ago

(opens in new tab)

4 other SEBI-registered advisors have active short-term BUY calls on this stock

Advisor consensus · same horizon·7 Sept · 2w ago

Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller

NewsEt-Markets·4 Sept · 3w ago

(opens in new tab)

Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block deal

NewsEt-Markets·3 Sept · 3w ago

(opens in new tab)
Neutral / worth noting (10)

Gland Pharma Limited's Board approved the acquisition of 100% equity share capital of Gland Pharma USA Inc. from Gland Pharma International Pte. Ltd. This move aims to streamline the corporate structu

NSE · Outcome of Board Meeting·13 Sept · 1w ago

(opens in new tab)

Fosun Pharma sells 4.5% stake in Gland Pharma for Rs 2,121 crore

NewsHbl·5 Sept · 2w ago

(opens in new tab)

Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 crore

NewsEt-Markets·4 Sept · 3w ago

(opens in new tab)

Fosun Pharma sells 6% stake in Gland Pharma for ₹2,800 crore; three mutual funds pick up shares

NewsCnbc-Tv18·4 Sept · 3w ago

(opens in new tab)

Block deal alert! Gland Pharma shares in focus as promoter Fosun to sell 5% stake for Rs 2,279 crore

NewsEt-Markets·4 Sept · 3w ago

(opens in new tab)
Weighs against the BUY call (5)

Gland Pharma shares fall after ₹2,100 crore block deal; Promoter likely seller

NewsCnbc-Tv18·4 Sept · 3w ago

(opens in new tab)

Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller

NewsEt-Markets·4 Sept · 3w ago

(opens in new tab)

2 advisors have active long-term SELL calls on this stock

Advisor consensus · adjacent horizon·12 Aug · 1mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Rakesh Bansal

Every call and its outcome